5768 AMH COUT WEIK 101
SB 5768 - H AMD 774
By Representative Couture
NOT ADOPTED 04/20/2023
On page 5, beginning on line 6, after "Sec. 6." strike all material through "immediately." on line 9 and insert "(1) The Washington state institute for public policy shall study and analyze the following:
(a) Any licensure or federal law compliance concerns related to the program established under section 2 of this act;
(b) The current regulatory status of mifepristone;
(c) Any potential liability for the state's role in the program and ways to mitigate any potential liability identified; and
(d) Which state agency is best suited to administer the program established under section 2 of this act based on the agency's current scope of duties, experience with prescription drugs and health care providers, and cost-effectiveness.
(2) The Washington state institute for public policy shall submit a report of the findings to the appropriate committees of the legislature by December 1, 2023.
NEW SECTION. Sec. 7. Sections 1 through 5 of this act take effect July 1, 2024."
Correct the title.
| EFFECT: Removes the emergency clause and moves back the effective date to July 1, 2024. Requires the Washington State Institute for Public Policy (WSIPP) to study and analyze (1) any licensure or federal law compliance concerns related to the program to deliver, dispense, and distribute abortion medications; (2) the current regulatory status of Mifepristone; (3) any potential liability for the state's role in the program; and (4) which state agency is best suited to administer the program. Requires WSIPP to submit a report of the findings to the appropriate committees of the Legislature by December 1, 2023. |
--- END ---